SLC7A11 and cancer: Notably, certain types of cancer, such as Kirsten rat sarcoma viral oncogene (KRAS)-mutant lung adenocarcinomas and pancreatic cancer, are highly sensitive to the intervention targeting SLC7A11[50,51].